Schneider Paul R 4

What Happened

• Paul R. Schneider, EVP and General Counsel of Zymeworks (ZYME), received two compensation awards on May 13, 2026 totaling 297,000 derivative units: 178,000 and 119,000. Both grants are reported at $0.00, indicating no cash purchase at grant; the filing classifies these as derivative awards (code A).

Key Details

• Transaction date: 2026-05-13; Form filed: 2026-05-15 (timely).
• Award amounts: 178,000 and 119,000 derivative units (total 297,000).
• Reported price: $0.00 for each grant (typical for compensation awards/RSUs).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes:
  • F1: A stock option tranche vests 25% on the first anniversary of the grant, then monthly over the following 36 months.
  • F2: Each RSU represents the contingent right to receive one share of common stock upon vesting.
  • F3: RSUs vest in four equal annual installments beginning on the first anniversary of the grant date.
• Transaction code: A (award/grant). No 10b5-1, tax-withholding, or late-filing flags indicated in the excerpt.

Context

• These are compensation awards (options and RSUs) that vest over time; they do not represent an immediate open-market purchase or sale and therefore are not a direct market signal of the insider buying or selling stock.
• RSUs convert to one share per unit when they vest; the option vesting schedule means underlying shares become available gradually if and when vesting conditions are met.